Science brief
From Nanoscale Chemistry to Orbital Tomography
Israeli breakthroughs in molecular coatings and immune-driven aging lead an inventory spanning orbital tomography and fundamental physics.
Science
Technion scientists proved cancer immunotherapy success is decided during early treatment — exposing static pre-treatment biopsies as an unreliable clinical guide.
BackgroundImmune checkpoint inhibitors stimulate a patient's own immune system to attack malignant tumors, but fewer than half of cancer patients respond favorably. Oncologists traditionally rely on pre-treatment tissue biopsies to predict whether patients will benefit from checkpoint inhibitor drugs.
- Prof. Dvir Aran and Dr. Zhongyang Lin analyzed longitudinal single-cell datasets across multiple malignancies, uncovering 4 conserved tumor immune microenvironment states.
- Cellular transitions observed during the initial treatment cycle correlated directly with patient survival rates and long-term remission outcomes.
- The team partnered with the German Cancer Consortium to validate real-time therapeutic adjustments aimed at steering non-responding tumors toward favorable states.
Science
Clarivate shortlisted Weizmann chemist Jacob Sagiv for a Nobel Prize — honoring molecular coating research that underpins modern semiconductor manufacturing.
BackgroundClarivate relies on quantitative citation data to identify elite researchers whose research footprint matches past Nobel Prize recipients. Sagiv invented self-assembled monolayers in the 1980s, creating chemical methods to organize organic molecules into dense, spontaneous protective coatings on solid surfaces.
- Sagiv shares the 2026 citation honor with American researchers David Allara and Ralph Nuzzo for opening the field of surface chemistry and molecular self-assembly.
- The molecular layering technique became the structural foundation for advanced nanolithography, chemical sensors, and modern semiconductor chip manufacturing.
- The Weizmann Institute framed the citation as validation that long-term Israeli basic chemistry research remains pivotal to the global microelectronics supply chain.
Science
Hebrew University researchers proved rapid aging stems from misdirected immune inflammation — opening a path to treat genetic degeneration by muting cellular alarms.
BackgroundPremature aging disorders such as Bloom syndrome have long been regarded as irreversible cellular consequences of defective DNA repair mechanisms. The cGAS protein acts as an innate immune sentinel, detecting misplaced viral DNA inside cell fluid to spark defense responses.
- The team led by Dr. Marva Bergman and Prof. Itamar Harel discovered that leaked self-DNA fragments trick the cGAS sensor into sustaining toxic inflammation.
- Genetically silencing the cGAS sensor restored organ tissue health and extended vertebrate lifespan without correcting the underlying genetic DNA repair mutations.
- The findings establish an actionable target for pharmaceutical developers seeking to halt degenerative organ decline using existing anti-inflammatory drug candidates.
Science
The CloudCT satellite transmitted its first orbital scans — applying 3D medical-style tomography to resolve the biggest blind spot in climate modeling.
BackgroundSmall convective clouds reflect solar radiation and redistribute heat across the atmosphere, yet their internal microphysics represent the largest source of climate modeling error. CloudCT deploys a fleet of miniaturized satellites to capture simultaneous multi-angle polarized imagery of cloud fields.
- Launched on a SpaceX flight, the satellite returned dual-view polarized images over Europe, validating onboard optics and real-time computing systems.
- Technion's Prof. Yoav Schechner and Weizmann's Prof. Ilan Koren designed the payload to perform computed tomography on clouds, mirroring hospital CT technology.
- The mission will deliver high-resolution vertical profiling data to refine global circulation models and clarify how aerosols modify cloud reflectivity.
Science
Science
Science
Science
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.
